300357 Stock Overview
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.69 |
| 52 Week High | CN¥47.72 |
| 52 Week Low | CN¥18.44 |
| Beta | 0.53 |
| 1 Month Change | 4.27% |
| 3 Month Change | 1.76% |
| 1 Year Change | -48.83% |
| 3 Year Change | -67.71% |
| 5 Year Change | -11.01% |
| Change since IPO | 321.30% |
Recent News & Updates
Shareholder Returns
| 300357 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 7.2% | 4.9% | 2.1% |
| 1Y | -48.8% | -13.4% | -14.2% |
Return vs Industry: 300357 underperformed the CN Pharmaceuticals industry which returned -14.4% over the past year.
Return vs Market: 300357 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 300357 volatility | |
|---|---|
| 300357 Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 7.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300357 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300357's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,709 | Gengxi Hu | www.wolwobiotech.com |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a farinae farinae drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kits; and Changdian II, a house dust mite skin pricking diagnostic kits. It also involved in the research and development of stem cells and medical artificial intelligence solutions.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Fundamentals Summary
| 300357 fundamental statistics | |
|---|---|
| Market cap | CN¥12.40b |
| Earnings (TTM) | CN¥316.91m |
| Revenue (TTM) | CN¥881.30m |
39.1x
P/E Ratio14.1x
P/S RatioIs 300357 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300357 income statement (TTM) | |
|---|---|
| Revenue | CN¥881.30m |
| Cost of Revenue | CN¥40.98m |
| Gross Profit | CN¥840.32m |
| Other Expenses | CN¥523.40m |
| Earnings | CN¥316.91m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Apr 28, 2024
| Earnings per share (EPS) | 0.61 |
| Gross Margin | 95.35% |
| Net Profit Margin | 35.96% |
| Debt/Equity Ratio | 2.1% |
How did 300357 perform over the long term?
See historical performance and comparison